MedX Health Corp
MedX Health Corp MDXHF Peers
See (MDXHF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDXHF | $0.00 | +0.00% | 12.26M | -0.08 | -$0.01 | N/A |
| SMMNY | $26.81 | -2.12% | 120.29B | 25.78 | $1.04 | +0.99% |
| SEMHF | $53.62 | -0.66% | 60.13B | 26.81 | $2.00 | +2.06% |
| RYLPF | $24.05 | -3.15% | 22.24B | 82.92 | $0.29 | +3.92% |
| SONVF | $323.21 | +2.29% | 19.26B | 28.13 | $11.49 | +1.76% |
| SONVY | $64.58 | +1.03% | 19.24B | 28.45 | $2.27 | +1.73% |
| SNNUF | $14.60 | +1.88% | 12.77B | 31.05 | $0.47 | +2.57% |
| CHEOY | $87.40 | +0.62% | 11.43B | 47.76 | $1.83 | +1.64% |
| CHEOF | $168.00 | -1.15% | 10.96B | 46.41 | $3.62 | +1.65% |
| WILYY | $18.78 | N/A | 8.00B | 18.59 | $1.01 | N/A |
Stock Comparison
MDXHF vs SMMNY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SMMNY has a market cap of 120.29B. Regarding current trading prices, MDXHF is priced at $0.00, while SMMNY trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SMMNY's P/E ratio is 25.78. In terms of profitability, MDXHF's ROE is +0.43%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, MDXHF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs SEMHF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SEMHF has a market cap of 60.13B. Regarding current trading prices, MDXHF is priced at $0.00, while SEMHF trades at $53.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SEMHF's P/E ratio is 26.81. In terms of profitability, MDXHF's ROE is +0.43%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, MDXHF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs RYLPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, RYLPF has a market cap of 22.24B. Regarding current trading prices, MDXHF is priced at $0.00, while RYLPF trades at $24.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas RYLPF's P/E ratio is 82.92. In terms of profitability, MDXHF's ROE is +0.43%, compared to RYLPF's ROE of -0.06%. Regarding short-term risk, MDXHF is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs SONVF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SONVF has a market cap of 19.26B. Regarding current trading prices, MDXHF is priced at $0.00, while SONVF trades at $323.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SONVF's P/E ratio is 28.13. In terms of profitability, MDXHF's ROE is +0.43%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, MDXHF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs SONVY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SONVY has a market cap of 19.24B. Regarding current trading prices, MDXHF is priced at $0.00, while SONVY trades at $64.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SONVY's P/E ratio is 28.45. In terms of profitability, MDXHF's ROE is +0.43%, compared to SONVY's ROE of +0.26%. Regarding short-term risk, MDXHF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs SNNUF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SNNUF has a market cap of 12.77B. Regarding current trading prices, MDXHF is priced at $0.00, while SNNUF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SNNUF's P/E ratio is 31.05. In terms of profitability, MDXHF's ROE is +0.43%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, MDXHF and SNNUF have similar daily volatility (0.00).
MDXHF vs CHEOY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CHEOY has a market cap of 11.43B. Regarding current trading prices, MDXHF is priced at $0.00, while CHEOY trades at $87.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CHEOY's P/E ratio is 47.76. In terms of profitability, MDXHF's ROE is +0.43%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, MDXHF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CHEOF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CHEOF has a market cap of 10.96B. Regarding current trading prices, MDXHF is priced at $0.00, while CHEOF trades at $168.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CHEOF's P/E ratio is 46.41. In terms of profitability, MDXHF's ROE is +0.43%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, MDXHF and CHEOF have similar daily volatility (0.00).
MDXHF vs WILYY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, WILYY has a market cap of 8.00B. Regarding current trading prices, MDXHF is priced at $0.00, while WILYY trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas WILYY's P/E ratio is 18.59. In terms of profitability, MDXHF's ROE is +0.43%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, MDXHF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs WILLF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, WILLF has a market cap of 7.46B. Regarding current trading prices, MDXHF is priced at $0.00, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas WILLF's P/E ratio is 18.13. In terms of profitability, MDXHF's ROE is +0.43%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, MDXHF and WILLF have similar daily volatility (0.00).
MDXHF vs GNGBY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, GNGBY has a market cap of 5.42B. Regarding current trading prices, MDXHF is priced at $0.00, while GNGBY trades at $19.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas GNGBY's P/E ratio is 35.09. In terms of profitability, MDXHF's ROE is +0.43%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, MDXHF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs GNGBF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, MDXHF is priced at $0.00, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, MDXHF's ROE is +0.43%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, MDXHF is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs AMBBY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, AMBBY has a market cap of 4.01B. Regarding current trading prices, MDXHF is priced at $0.00, while AMBBY trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas AMBBY's P/E ratio is 72.33. In terms of profitability, MDXHF's ROE is +0.43%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, MDXHF is less volatile compared to AMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs NHNKY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, NHNKY has a market cap of 3.91B. Regarding current trading prices, MDXHF is priced at $0.00, while NHNKY trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas NHNKY's P/E ratio is 16.89. In terms of profitability, MDXHF's ROE is +0.43%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, MDXHF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs AMBFF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, AMBFF has a market cap of 3.52B. Regarding current trading prices, MDXHF is priced at $0.00, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, MDXHF's ROE is +0.43%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, MDXHF and AMBFF have similar daily volatility (0.00).
MDXHF vs NHNKF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, MDXHF is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, MDXHF's ROE is +0.43%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, MDXHF and NHNKF have similar daily volatility (0.00).
MDXHF vs VTRLY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, MDXHF is priced at $0.00, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, MDXHF's ROE is +0.43%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, MDXHF and VTRLY have similar daily volatility (0.00).
MDXHF vs GNNDY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, GNNDY has a market cap of 2.07B. Regarding current trading prices, MDXHF is priced at $0.00, while GNNDY trades at $42.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas GNNDY's P/E ratio is 17.03. In terms of profitability, MDXHF's ROE is +0.43%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, MDXHF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs STSEY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, MDXHF is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas STSEY's P/E ratio is 39.41. In terms of profitability, MDXHF's ROE is +0.43%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, MDXHF and STSEY have similar daily volatility (0.00).
MDXHF vs SSII Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SSII has a market cap of 1.95B. Regarding current trading prices, MDXHF is priced at $0.00, while SSII trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SSII's P/E ratio is -91.36. In terms of profitability, MDXHF's ROE is +0.43%, compared to SSII's ROE of -1.33%. Regarding short-term risk, MDXHF is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs GGNDF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, MDXHF is priced at $0.00, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, MDXHF's ROE is +0.43%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, MDXHF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs OSSFF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, MDXHF is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, MDXHF's ROE is +0.43%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, MDXHF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs DWRKF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, MDXHF is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, MDXHF's ROE is +0.43%, compared to DWRKF's ROE of N/A. Regarding short-term risk, MDXHF and DWRKF have similar daily volatility (0.00).
MDXHF vs MCRPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, MDXHF is priced at $0.00, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, MDXHF's ROE is +0.43%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, MDXHF is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs OSSUY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, MDXHF is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, MDXHF's ROE is +0.43%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, MDXHF and OSSUY have similar daily volatility (0.00).
MDXHF vs MEDGF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, MDXHF is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, MDXHF's ROE is +0.43%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, MDXHF and MEDGF have similar daily volatility (0.00).
MDXHF vs DRWKF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, DRWKF has a market cap of 1.17B. Regarding current trading prices, MDXHF is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas DRWKF's P/E ratio is 9.01. In terms of profitability, MDXHF's ROE is +0.43%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, MDXHF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs XVIPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, MDXHF is priced at $0.00, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, MDXHF's ROE is +0.43%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, MDXHF and XVIPF have similar daily volatility (0.00).
MDXHF vs LFTSF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, MDXHF is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, MDXHF's ROE is +0.43%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, MDXHF and LFTSF have similar daily volatility (0.00).
MDXHF vs DGWPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, DGWPF has a market cap of 925.04M. Regarding current trading prices, MDXHF is priced at $0.00, while DGWPF trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas DGWPF's P/E ratio is 6.88. In terms of profitability, MDXHF's ROE is +0.43%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, MDXHF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs ELEAF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, MDXHF is priced at $0.00, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, MDXHF's ROE is +0.43%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, MDXHF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CALZF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CALZF has a market cap of 829.01M. Regarding current trading prices, MDXHF is priced at $0.00, while CALZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CALZF's P/E ratio is 120.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, MDXHF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs MDRSF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, MDXHF is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, MDXHF's ROE is +0.43%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, MDXHF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs AVMR Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, MDXHF is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas AVMR's P/E ratio is -18.34. In terms of profitability, MDXHF's ROE is +0.43%, compared to AVMR's ROE of -0.24%. Regarding short-term risk, MDXHF and AVMR have similar daily volatility (0.00).
MDXHF vs CLVSF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, MDXHF is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, MDXHF's ROE is +0.43%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, MDXHF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs HYBT Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, MDXHF is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas HYBT's P/E ratio is N/A. In terms of profitability, MDXHF's ROE is +0.43%, compared to HYBT's ROE of -0.02%. Regarding short-term risk, MDXHF and HYBT have similar daily volatility (0.00).
MDXHF vs IOBCF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, IOBCF has a market cap of 326.64M. Regarding current trading prices, MDXHF is priced at $0.00, while IOBCF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas IOBCF's P/E ratio is 37.17. In terms of profitability, MDXHF's ROE is +0.43%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, MDXHF is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs SNWV Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SNWV has a market cap of 293.04M. Regarding current trading prices, MDXHF is priced at $0.00, while SNWV trades at $34.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SNWV's P/E ratio is -5.50. In terms of profitability, MDXHF's ROE is +0.43%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, MDXHF is less volatile compared to SNWV. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs EAPIF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, MDXHF is priced at $0.00, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, MDXHF's ROE is +0.43%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, MDXHF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CSSPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, MDXHF is priced at $0.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, MDXHF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CYBQY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CYBQY has a market cap of 261.21M. Regarding current trading prices, MDXHF is priced at $0.00, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, MDXHF's ROE is +0.43%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, MDXHF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CLLKF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CLLKF has a market cap of 259.03M. Regarding current trading prices, MDXHF is priced at $0.00, while CLLKF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CLLKF's P/E ratio is -8.52. In terms of profitability, MDXHF's ROE is +0.43%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, MDXHF and CLLKF have similar daily volatility (0.00).
MDXHF vs HTLZF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, MDXHF is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, MDXHF's ROE is +0.43%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, MDXHF and HTLZF have similar daily volatility (0.00).
MDXHF vs BCCOY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, BCCOY has a market cap of 221.56M. Regarding current trading prices, MDXHF is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, MDXHF's ROE is +0.43%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, MDXHF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs IMPZY Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, MDXHF is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, MDXHF's ROE is +0.43%, compared to IMPZY's ROE of -3.64%. Regarding short-term risk, MDXHF and IMPZY have similar daily volatility (0.00).
MDXHF vs AVHHL Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, AVHHL has a market cap of 191.65M. Regarding current trading prices, MDXHF is priced at $0.00, while AVHHL trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas AVHHL's P/E ratio is -3.25. In terms of profitability, MDXHF's ROE is +0.43%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, MDXHF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CYBQF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, MDXHF is priced at $0.00, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, MDXHF's ROE is +0.43%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, MDXHF and CYBQF have similar daily volatility (0.00).
MDXHF vs BRNHF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, MDXHF is priced at $0.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, MDXHF's ROE is +0.43%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, MDXHF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs EKDHF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, MDXHF is priced at $0.00, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, MDXHF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs JMDMF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, MDXHF is priced at $0.00, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, MDXHF's ROE is +0.43%, compared to JMDMF's ROE of N/A. Regarding short-term risk, MDXHF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs PXMBF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, PXMBF has a market cap of 149.60M. Regarding current trading prices, MDXHF is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, MDXHF's ROE is +0.43%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, MDXHF and PXMBF have similar daily volatility (0.00).
MDXHF vs BRSYF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, MDXHF is priced at $0.00, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas BRSYF's P/E ratio is 37.78. In terms of profitability, MDXHF's ROE is +0.43%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, MDXHF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs AMEUF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, MDXHF is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, MDXHF's ROE is +0.43%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, MDXHF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs VMTHF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, MDXHF is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas VMTHF's P/E ratio is -1.14. In terms of profitability, MDXHF's ROE is +0.43%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, MDXHF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs FDMDF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, MDXHF is priced at $0.00, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, MDXHF's ROE is +0.43%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, MDXHF and FDMDF have similar daily volatility (0.00).
MDXHF vs RSHUF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, MDXHF is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, MDXHF's ROE is +0.43%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, MDXHF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs CKMTF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, MDXHF is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, MDXHF's ROE is +0.43%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, MDXHF and CKMTF have similar daily volatility (0.00).
MDXHF vs SOMNF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, MDXHF is priced at $0.00, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, MDXHF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs DMTRF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, MDXHF is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, MDXHF's ROE is +0.43%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, MDXHF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs IPDQF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, MDXHF is priced at $0.00, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, MDXHF's ROE is +0.43%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, MDXHF is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs SNZZF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, MDXHF is priced at $0.00, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, MDXHF's ROE is +0.43%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, MDXHF is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs RDGL Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, RDGL has a market cap of 59.91M. Regarding current trading prices, MDXHF is priced at $0.00, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas RDGL's P/E ratio is -13.21. In terms of profitability, MDXHF's ROE is +0.43%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, MDXHF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs BLOZF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, BLOZF has a market cap of 51.32M. Regarding current trading prices, MDXHF is priced at $0.00, while BLOZF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas BLOZF's P/E ratio is -22.28. In terms of profitability, MDXHF's ROE is +0.43%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, MDXHF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs NVYTF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, MDXHF is priced at $0.00, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, MDXHF's ROE is +0.43%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, MDXHF is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs TLTFF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, TLTFF has a market cap of 32.97M. Regarding current trading prices, MDXHF is priced at $0.00, while TLTFF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas TLTFF's P/E ratio is -13.30. In terms of profitability, MDXHF's ROE is +0.43%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, MDXHF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs PYNKF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, PYNKF has a market cap of 28.70M. Regarding current trading prices, MDXHF is priced at $0.00, while PYNKF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas PYNKF's P/E ratio is -1.71. In terms of profitability, MDXHF's ROE is +0.43%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, MDXHF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs ELXMF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, MDXHF is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, MDXHF and ELXMF have similar daily volatility (0.00).
MDXHF vs KBBTF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, MDXHF is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, MDXHF's ROE is +0.43%, compared to KBBTF's ROE of N/A. Regarding short-term risk, MDXHF and KBBTF have similar daily volatility (0.00).
MDXHF vs EMITF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, MDXHF is priced at $0.00, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas EMITF's P/E ratio is -14.29. In terms of profitability, MDXHF's ROE is +0.43%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, MDXHF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs POSC Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, POSC has a market cap of 20.70M. Regarding current trading prices, MDXHF is priced at $0.00, while POSC trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas POSC's P/E ratio is 0.39. In terms of profitability, MDXHF's ROE is +0.43%, compared to POSC's ROE of +9.25%. Regarding short-term risk, MDXHF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs RMSL Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, RMSL has a market cap of 18.12M. Regarding current trading prices, MDXHF is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas RMSL's P/E ratio is 1.18. In terms of profitability, MDXHF's ROE is +0.43%, compared to RMSL's ROE of -1.94%. Regarding short-term risk, MDXHF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs ASAPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, ASAPF has a market cap of 16.99M. Regarding current trading prices, MDXHF is priced at $0.00, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas ASAPF's P/E ratio is -22.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, MDXHF and ASAPF have similar daily volatility (0.00).
MDXHF vs VPTDF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, VPTDF has a market cap of 14.71M. Regarding current trading prices, MDXHF is priced at $0.00, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas VPTDF's P/E ratio is -4.51. In terms of profitability, MDXHF's ROE is +0.43%, compared to VPTDF's ROE of +3.89%. Regarding short-term risk, MDXHF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs TMDIF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, MDXHF is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, MDXHF's ROE is +0.43%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, MDXHF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs DIZTF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, MDXHF is priced at $0.00, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, MDXHF's ROE is +0.43%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, MDXHF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs PLLWF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, MDXHF is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, MDXHF's ROE is +0.43%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, MDXHF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs IMEXF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, IMEXF has a market cap of 11.61M. Regarding current trading prices, MDXHF is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas IMEXF's P/E ratio is N/A. In terms of profitability, MDXHF's ROE is +0.43%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, MDXHF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs NGMDF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, MDXHF is priced at $0.00, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas NGMDF's P/E ratio is -5.50. In terms of profitability, MDXHF's ROE is +0.43%, compared to NGMDF's ROE of +2.16%. Regarding short-term risk, MDXHF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs ATBPF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, MDXHF is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, MDXHF's ROE is +0.43%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, MDXHF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs LXXGF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, MDXHF is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, MDXHF's ROE is +0.43%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, MDXHF and LXXGF have similar daily volatility (0.00).
MDXHF vs IRME Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, IRME has a market cap of 8.28M. Regarding current trading prices, MDXHF is priced at $0.00, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas IRME's P/E ratio is -3.83. In terms of profitability, MDXHF's ROE is +0.43%, compared to IRME's ROE of +506.40%. Regarding short-term risk, MDXHF is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs GTHP Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, GTHP has a market cap of 7.80M. Regarding current trading prices, MDXHF is priced at $0.00, while GTHP trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas GTHP's P/E ratio is -2.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to GTHP's ROE of +0.56%. Regarding short-term risk, MDXHF and GTHP have similar daily volatility (0.00).
MDXHF vs MKEAF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, MKEAF has a market cap of 6.59M. Regarding current trading prices, MDXHF is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, MDXHF's ROE is +0.43%, compared to MKEAF's ROE of +0.60%. Regarding short-term risk, MDXHF and MKEAF have similar daily volatility (0.00).
MDXHF vs DTXMF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, MDXHF is priced at $0.00, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, MDXHF's ROE is +0.43%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, MDXHF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs QLIS Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, MDXHF is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas QLIS's P/E ratio is 2.22. In terms of profitability, MDXHF's ROE is +0.43%, compared to QLIS's ROE of -8.21%. Regarding short-term risk, MDXHF and QLIS have similar daily volatility (0.00).
MDXHF vs RHNMF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, MDXHF is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, MDXHF's ROE is +0.43%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, MDXHF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs TBRIF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, TBRIF has a market cap of 4.95M. Regarding current trading prices, MDXHF is priced at $0.00, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas TBRIF's P/E ratio is -1.09. In terms of profitability, MDXHF's ROE is +0.43%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, MDXHF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs VYCO Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, VYCO has a market cap of 4.94M. Regarding current trading prices, MDXHF is priced at $0.00, while VYCO trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas VYCO's P/E ratio is -14.80. In terms of profitability, MDXHF's ROE is +0.43%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, MDXHF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs MICR Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, MDXHF is priced at $0.00, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas MICR's P/E ratio is -3.47. In terms of profitability, MDXHF's ROE is +0.43%, compared to MICR's ROE of -0.25%. Regarding short-term risk, MDXHF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs FZMD Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, MDXHF is priced at $0.00, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas FZMD's P/E ratio is 1.20. In terms of profitability, MDXHF's ROE is +0.43%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, MDXHF is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs ADMT Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, ADMT has a market cap of 4.30M. Regarding current trading prices, MDXHF is priced at $0.00, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas ADMT's P/E ratio is -6.36. In terms of profitability, MDXHF's ROE is +0.43%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, MDXHF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs NUMD Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, MDXHF is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas NUMD's P/E ratio is 5.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, MDXHF and NUMD have similar daily volatility (0.00).
MDXHF vs LBLTF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, MDXHF is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, MDXHF's ROE is +0.43%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, MDXHF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs BIEL Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, MDXHF is priced at $0.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas BIEL's P/E ratio is N/A. In terms of profitability, MDXHF's ROE is +0.43%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, MDXHF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs VANIW Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, MDXHF is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas VANIW's P/E ratio is N/A. In terms of profitability, MDXHF's ROE is +0.43%, compared to VANIW's ROE of -1.06%. Regarding short-term risk, MDXHF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs ALRTF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, ALRTF has a market cap of 2.92M. Regarding current trading prices, MDXHF is priced at $0.00, while ALRTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas ALRTF's P/E ratio is -0.15. In terms of profitability, MDXHF's ROE is +0.43%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, MDXHF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs KLYG Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, KLYG has a market cap of 2.27M. Regarding current trading prices, MDXHF is priced at $0.00, while KLYG trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas KLYG's P/E ratio is -18.00. In terms of profitability, MDXHF's ROE is +0.43%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, MDXHF is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs PMEDF Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, MDXHF is priced at $0.00, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, MDXHF's ROE is +0.43%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, MDXHF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDXHF.
MDXHF vs LLBO Comparison
MDXHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDXHF stands at 12.26M. In comparison, LLBO has a market cap of 2.17M. Regarding current trading prices, MDXHF is priced at $0.00, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDXHF currently has a P/E ratio of -0.08, whereas LLBO's P/E ratio is N/A. In terms of profitability, MDXHF's ROE is +0.43%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, MDXHF and LLBO have similar daily volatility (0.00).